Diabetic Skincare: GLP-1’s 2026 Impact

The work we’re seeing from formulators like ANJAC on GLP-1 treatments and their connection to diabetic skincare is forcing a real change in how we handle dermatology for this growing group of patients. These newer diabetes drugs do amazing things for metabolic health, but they also create brand new problems for skin integrity and comfort. So, do we need to throw out the old playbook for diabetic skincare?

The Interplay of GLP-1 Therapies and Skin Physiology

Glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide and liraglutide have totally changed how we manage type 2 diabetes. These drugs, approved by the FDA for both blood sugar and weight control, work by copying natural incretin hormones to trigger insulin and block glucagon, which fixes blood sugar and often leads to a lot of weight loss. But these effects don’t stop at glucose control. They ripple out to other body systems, especially the skin. When a patient loses a lot of weight quickly, their skin can struggle to keep up, losing elasticity and firmness and sometimes getting much drier or starting to sag, and even small changes to their nutrition can show up on their skin. A 2023 report from the American Academy of Dermatology Association (AAD) actually noted a rise in certain skin conditions for patients losing significant weight, including those on GLP-1 agonists, things like more irritation and, in some people, slower wound healing. It’s a chain reaction: the medication triggers physiological adjustments that then demand a new level of clinical attention for the skin.

Specific Dermatological Concerns for GLP-1 Users

The skin complaints from patients on GLP-1s are different from the classic diabetic dermatopathy we’re used to seeing. The main issue is xerosis, or just extreme dryness. We don’t have the full picture on why it happens, but the leading theory is that these big metabolic shifts, combined with the loss of subcutaneous fat, weaken the skin’s natural barrier. This leaves the skin open to environmental damage and can make existing conditions like eczema or contact dermatitis flare up. We also see a lot more sensitivity, where skin suddenly reacts to products that have been fine for years. Another big concern is skin elasticity and texture. As the fat underneath diminishes with weight loss, the skin has trouble bouncing back, especially if the patient is older or already had some collagen loss. This isn’t just a cosmetic problem. Poor skin integrity means micro-tears or more friction in skin folds, which could open the door to infections, a serious risk for any diabetic patient. The European Society of Dermatology (ESD) even updated their 2025 guidelines to say that proactive barrier support with humectant- and emollient-rich formulas is absolutely essential for these patients.

ANJAC’s Strategic Approach to Diabetic Skincare

ANJAC, a contract manufacturer that develops formulas for cosmetic and dermatological brands, has picked up on this clear need. Their goal is to develop specialized skincare solutions that support patients taking these drugs, not to create their own GLP-1s. Their strategy is built on figuring out the specific biochemical and physiological changes happening in the skin of people on GLP-1 therapies, which means investigating how these new metabolic pathways affect things like ceramide synthesis, hyaluronic acid production, and the all-important lipid barrier. The research ANJAC is backing is all about finding and validating active ingredients that can push back against these skin changes. For instance, they’re looking into new combinations of biomimetic lipids that can effectively patch up a damaged skin barrier. The work is all about targeted restoration. Basically, they’re working to solve these dermatological problems before they get out of hand for patients.

Key Skincare Ingredients and Formulations

For someone on a GLP-1, a basic moisturizer from the drugstore probably isn’t going to cut it. Formulations have to be powerful but also extremely gentle. Here are the ingredient types ANJAC and other formulators are building around:

• Humectants: Ingredients like hyaluronic acid (using different molecular weights to hydrate at multiple depths) and glycerin are the foundation. They pull moisture into the skin to fight the intense dryness people report.
• Emollients and Occlusives: To seal in that moisture and rebuild the skin barrier, you need ingredients like ceramides, squalane, shea butter, and petrolatum. Ceramides are especially key since they’re natural lipids that form a huge part of the skin barrier, so putting them back is critical for compromised skin.
• Antioxidants: While they don’t fix dryness directly, antioxidants like Vitamin E, Vitamin C, and green tea extract defend the skin from oxidative stress, which can increase during metabolic imbalance. They help keep skin resilient.
• Soothing Agents: Things like oat extract, allantoin, and bisabolol can calm down irritated skin, which is common given the new sensitivities some GLP-1 users find they have.
• Gentle Cleansers: A harsh soap will strip away natural oils and just make the dryness worse. The formulations should always be sulfate-free and pH-balanced to protect the skin’s acid mantle.

It’s all about how these ingredients work together. You can’t just mix a few good things in a vat and call it a day. The ratios, the delivery systems, and the texture of the product itself have to be fine-tuned for the formula to actually work and feel good on sensitive skin, which is exactly where a formulator’s expertise, like ANJAC’s work with sensitive skin types, becomes so important.

Integrating Skincare into Diabetic Management

This whole discussion about GLP-1s and skin has to happen outside the derm’s office. Primary care docs, endocrinologists, and dietitians are starting to get that good diabetic care has to include watching out for skin health. That means educating the patient from the get-go. When someone starts on a GLP-1 agonist, the talk about diet and potential stomach issues should also include what to expect with their skin and how to handle it. Dermatologists are still central, of course, for diagnosing and managing the more serious skin problems, prescribing stronger topicals, or offering procedures for things like major skin laxity. But the day-to-day work is up to the patient, with guidance from their whole care team. This team-based approach makes skin health an integrated part of a patient’s long-term diabetes and weight management. The American Diabetes Association (ADA) even put out a consensus statement in early 2026 that pushed for this multidisciplinary approach, including a dermatological check-in for patients starting these new drugs.

The Future of Diabetic Skincare Innovation

The whole field of diabetic skincare is changing fast, and it’s all because of medical treatments like GLP-1 agonists. We’re going to see much more personalized formulas, designed not just for “diabetic skin” in general but for the specific issues tied to certain drugs and treatment plans. Research into the skin microbiome and how it reacts to these metabolic changes is another promising path. We might see probiotic or prebiotic skincare solutions emerge from that. We should also expect more proper clinical trials that test skincare on GLP-1 patient groups, which will give us the hard evidence we need for solid clinical guidelines. Companies like ANJAC, with their scientific approach to formulation, are leading this charge, making sure that as the medicine advances, the dermatology care can keep up and support patients through their whole treatment. The ultimate objective is to improve a patient’s overall quality of life, and you can’t do that if their skin is a constant source of discomfort. The rise of GLP-1 treatments requires a similar jump forward in diabetic skincare, and for both patients and providers, getting a handle on these new dermatological effects is no longer optional.